Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Peripheral Nerve Sheath Tumor”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Large-scale testing (Phase 3)Study completedNCT00346164
What this trial is testing

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+26 more
Children's Oncology Group 588
Early research (Phase 1)Study completedNCT04811196
What this trial is testing

Different Dosing Schedules of Selinexor in Sarcoma Patients

Who this might be right for
Soft Tissue SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Leiomyosarcoma+1 more
University Health Network, Toronto 56
Early research (Phase 1)Study completedNCT04465643
What this trial is testing

Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
Nerve Sheath Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Large-scale testing (Phase 3)Study completedNCT00061984
What this trial is testing

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 455
Testing effectiveness (Phase 2)Study completedNCT00245102
What this trial is testing

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more
National Cancer Institute (NCI) 147
Testing effectiveness (Phase 2)Looking for participantsNCT05732831
What this trial is testing

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 225
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Large-scale testing (Phase 3)Study completedNCT00002641
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 350
Not applicableUnknownNCT01218139
What this trial is testing

Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients

Who this might be right for
Neurofibromatosis Type 1
KU Leuven 50
Not applicableUnknownNCT01218152
What this trial is testing

Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs

Who this might be right for
Neurofibromatosis Type 1
KU Leuven 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Testing effectiveness (Phase 2)Study completedNCT00589784
What this trial is testing

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Who this might be right for
CNS CancerMeningiomaIntracranial Hemangiopericytoma+2 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT02691026
What this trial is testing

Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery

Who this might be right for
Malignant Peripheral Nerve Sheath Tumour (MPNST)
Oslo University Hospital 8
Large-scale testing (Phase 3)UnknownNCT00334854
What this trial is testing

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
European Paediatric Soft Tissue Sarcoma Study Group 250
Testing effectiveness (Phase 2)Study completedNCT02452554
What this trial is testing

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

Who this might be right for
Pleuropulmonary BlastomaRecurrent Malignant Peripheral Nerve Sheath TumorRecurrent Neuroblastoma+3 more
Children's Oncology Group 62
Not applicableWithdrawnNCT01567787
What this trial is testing

Proton Radiation Therapy for Spinal Tumors

Who this might be right for
Nerve Sheath TumorsNeurofibroma
University of Florida
Testing effectiveness (Phase 2)Active Not RecruitingNCT03872427
What this trial is testing

Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmNF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor+1 more
National Cancer Institute (NCI) 54
Early research (Phase 1)Looking for participantsNCT05245500
What this trial is testing

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Who this might be right for
MesotheliomaNon Small Cell Lung CancerMalignant Peripheral Nerve Sheath Tumors+3 more
Bristol-Myers Squibb 336
Next Page